These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6540521)

  • 1. Vascular plasminogen activator levels and thromboembolic disease in patients with gynecologic malignancies.
    Gore M; Miller KE; Soong SJ; Clarke-Pearson DL; Pizzo SV
    Am J Obstet Gynecol; 1984 Aug; 149(8):830-4. PubMed ID: 6540521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective release of vascular plasminogen activator in patients with gynecologic malignancies.
    Doman KA; Gore M; Miller KE; Soong SJ; Clarke-Pearson DL; Pizzo SV
    Gynecol Oncol; 1986 Feb; 23(2):141-8. PubMed ID: 3080356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the plasma plasminogen activators in patients with malignant gynecologic tumors].
    Shimada H; Ikeuchi M; Suwa M; Michimoto T; Ono Y; Tanada S; Himeno K; Hoshino T; Takashima E
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1353-9. PubMed ID: 2511260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of von Willebrand factor and plasminogen activator in patients with arterial thromboembolism--with special reference to their correlation to the increased catabolism of both fibrinogen and platelets.
    Matsumoto M; Uchiyama T; Kobayashi N; Maekawa T
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1105-14. PubMed ID: 2588960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy.
    Clarke-Pearson DL; Synan IS; Hinshaw WM; Coleman RE; Creasman WT
    Obstet Gynecol; 1984 Jan; 63(1):92-8. PubMed ID: 6691021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
    von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
    Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma levels of urokinase-type plasminogen activator with endometrial and cervical cancer.
    Koelbl H; Kirchheimer JC; Tatra G; Christ G; Binder BR
    Obstet Gynecol; 1988 Aug; 72(2):252-6. PubMed ID: 3134631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin.
    Clarke-Pearson DL; Coleman RE; Synan IS; Hinshaw W; Creasman WT
    Am J Obstet Gynecol; 1983 Mar; 145(5):606-13. PubMed ID: 6338722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A colorimetric assay for releasable plasminogen activator.
    Campbell EE; Shifman MA; Lewis JG; Pasqua JJ; Pizzo SV
    Clin Chem; 1982 May; 28(5):1125-8. PubMed ID: 6210467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early hemostatic disorders in patients with gynecologic tumors.
    Di Roberto P; Benedetti Panici P; Scambia G; Laghi F; Margariti PA; Mancuso S; Bompiani A
    Eur J Gynaecol Oncol; 1986; 7(2):109-12. PubMed ID: 2941303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
    Tkaczyk M; Owczarek D; Finke D; Nowicki M
    Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunosuppressive substance in patients with gynecologic malignancies and in pregnant women.
    Yamashita K; Hayashi H; Mure K; Ishikawa M; Shimizu T
    Cancer; 1986 Jan; 57(1):69-74. PubMed ID: 3940624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous and arterial thromboembolic disease in women using oral contraceptives.
    Miller KE; Pizzo SV
    Am J Obstet Gynecol; 1982 Dec; 144(7):824-7. PubMed ID: 6890768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and highly sensitive solid-phase radioassay for plasminogen activators.
    Roche PC; Campeau JD; Shaw ST
    Thromb Res; 1983 Jul; 31(2):269-77. PubMed ID: 6685354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D; Stassen JM; Verstraete M
    J Clin Invest; 1983 Feb; 71(2):368-76. PubMed ID: 6681615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of postoperative venous thromboemboli in gynecologic oncology: a prospective study of 382 patients.
    Clarke-Pearson DL; Synan IS; Colemen RE; Hinshaw W; Creasman WT
    Am J Obstet Gynecol; 1984 Apr; 148(8):1051-4. PubMed ID: 6711637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients.
    Sier CF; Stephens R; Bizik J; Mariani A; Bassan M; Pedersen N; Frigerio L; Ferrari A; Danø K; Brünner N; Blasi F
    Cancer Res; 1998 May; 58(9):1843-9. PubMed ID: 9581823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin fragment 21-1 in gynecologic malignancy: comparison with cancer antigen 125 and squamous cell carcinoma-related antigen.
    Inaba N; Negishi Y; Fukasawa I; Okajima Y; Ota Y; Tanaka K; Matsui H; Iwasaki H; Sudo H; Tanaka N
    Tumour Biol; 1995; 16(6):345-52. PubMed ID: 7569681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospective investigation of postoperative lower extremity deep venous thrombosis in gynecological procedures].
    Liu YZ; Zhang ZY; Guo SL; He W; Zhang XR; Wang SZ; Liu CD; Li JF; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):107-10. PubMed ID: 16640859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk and prevention of thromboembolism complications in gynecologic malignancies].
    Graf AH; Graf B; Traun H; Staudach A
    Gynakol Geburtshilfliche Rundsch; 1996; 36(1):37-9. PubMed ID: 8737522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.